Topical Formula Reduces Retinoid Irritation in Pilot Study
A topical formulation combining tretinoin with a skin-barrier-supporting ingredient reduces redness, dryness, and irritation associated with retinoid use.
A topical formulation combining tretinoin with a skin-barrier-supporting ingredient reduces redness, dryness, and irritation associated with retinoid use.
The botulinum neurotoxin type E candidate is designed for a faster onset and shorter duration of effect than currently available neurotoxin treatments.